Less than the sum of its parts: failure of a tenofovir-abacavir-Lamivudine triple-nucleoside regimen

J Infect Dis. 2005 Dec 1;192(11):1867-8. doi: 10.1086/498070. Epub 2005 Oct 25.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Adenine / analogs & derivatives*
  • Adenine / therapeutic use
  • Anti-HIV Agents / therapeutic use*
  • Dideoxynucleosides / therapeutic use*
  • Drug Resistance, Viral*
  • Drug Therapy, Combination
  • HIV Infections / drug therapy*
  • HIV Infections / virology
  • HIV-1 / drug effects
  • Humans
  • Lamivudine / therapeutic use*
  • Organophosphonates / therapeutic use*
  • Randomized Controlled Trials as Topic
  • Reverse Transcriptase Inhibitors / therapeutic use*
  • Tenofovir
  • Treatment Failure

Substances

  • Anti-HIV Agents
  • Dideoxynucleosides
  • Organophosphonates
  • Reverse Transcriptase Inhibitors
  • Lamivudine
  • Tenofovir
  • Adenine
  • abacavir